MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights
12 mai 2015 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - May 12, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Initiates Clinical Study on Fortetropin(R) Dose Response
11 mai 2015 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - May 11, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Announces the Re Muscle Health(TM) Series Powered by Fortetropin(R)
30 mars 2015 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 30, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights
27 mars 2015 16h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 27, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference
23 févr. 2015 07h30 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 23, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Research Selected to Be Presented at International Conference on Molecular and Cellular Biology
11 févr. 2015 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 11, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation's Preclinical Study of Fortetropin's(TM) Mechanism of Action Demonstrate Regulatory Effects on Three Key Muscle Health Pathways
22 janv. 2015 08h00 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jan 22, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present at the Eighth Annual OneMedForum Conference on January 13, 2015
07 janv. 2015 07h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jan 7, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces $1.81 Million Registered Direct Offering
18 nov. 2014 09h25 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 18, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update
14 nov. 2014 10h30 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...